In melanoma, regulation of PD-L1 expression by DNA promoter methylation has recently been demonstrated in three melanoma cell lines that showed increased PD-L1 expression upon treatment with the hypomethylating agent 5-azacytidine [23]. This evidence concerns the gene CD274 and melanoma.